about
CTLA4 polymorphisms and de novo malignancy risk after renal transplantation in Chinese recipients.Sirolimus for GVHD prophylaxis in allogeneic stem cell transplantation.The role and value of sirolimus administration in kidney and liver transplantation.Nanomedicines in renal transplant rejection--focus on sirolimusHistorical perspectives in kidney transplantation: an updated review.The effect of mTOR inhibition alone or combined with MEK inhibitors on brain metastasis: an in vivo analysis in triple-negative breast cancer models.mTORC1 inhibition via rapamycin promotes triacylglycerol lipolysis and release of free fatty acids in 3T3-L1 adipocytes.
P2860
Q35033897-397A4478-C5C2-40F5-BDDC-03776D35F72BQ35845541-14DB4999-1DE3-47BF-BCD5-099012E54123Q36652031-6104B094-A271-4953-8A34-7D2B86ED8A93Q36920414-F4ECD7C9-0755-44EA-9A3C-8A29858A9C6DQ38373018-EA9C6150-3DCD-4D4C-99F5-DAA24DD918E8Q39577741-A2A2910D-A256-4EF0-9CCC-E9E09D12DA46Q41441726-946F64B1-9B4E-4920-9D77-B58A57ABE63D
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Sirolimus: a ten-year perspective.
@ast
Sirolimus: a ten-year perspective.
@en
type
label
Sirolimus: a ten-year perspective.
@ast
Sirolimus: a ten-year perspective.
@en
prefLabel
Sirolimus: a ten-year perspective.
@ast
Sirolimus: a ten-year perspective.
@en
P1476
Sirolimus: a ten-year perspective.
@en
P2093
P356
10.1016/J.TRANSPROCEED.2003.11.039
P407
P577
2004-01-01T00:00:00Z